Wellness and Prevention After DCIS

If you have been diagnosed with ductal carcinoma in situ (DCIS), you are in a powerful position. You have an early warning — and that means you have time to think carefully and take meaningful steps to protect your health.

The choices on this page are supported by research and may help reduce the risk of DCIS progressing to invasive breast cancer, the risk of a new breast cancer in the other breast, and the risk of other diseases. Some have stronger evidence behind them than others, and we have noted this throughout so you can decide where to focus first.

You do not need to do everything at once. Small, consistent changes add up. Start where you can.

1. Monitoring After DCIS

Know How Your Breasts Normally Look and Feel

Major medical organizations no longer recommend a structured monthly self-exam, but breast self-awareness — knowing what is normal for you so you can notice changes — remains important.¹ This is especially true after a DCIS diagnosis. In a 2023 Kaiser Permanente study, about 1 in 5 second breast cancers in women previously treated for DCIS were first noticed by the women themselves.² Tell your doctor right away about new lumps, skin changes, nipple changes, or unusual pain.

Stay Current With Imaging and Follow-Up

After breast-conserving treatment for DCIS, national guidelines recommend a follow-up mammogram of the treated breast within 6 to 12 months, followed by annual mammograms of both breasts with no end date.³ Women in active surveillance protocols follow a different schedule. Talk with your medical team about the right plan for you.

Mammography is a useful tool with real tradeoffs. It can detect cancers that would never have caused harm — a phenomenon called overdiagnosis. How often this happens in DCIS specifically is not yet known; published estimates range from roughly 10% to upward of 20%, depending on the population studied and how overdiagnosis is defined.⁴ Because overdiagnosis can only be confirmed in hindsight, active surveillance trials are now testing whether carefully selected low-risk DCIS can safely be monitored rather than treated right away.⁵ Mammography also involves a small amount of radiation and some compression discomfort. On the whole, the benefits of screening in reducing breast cancer deaths substantially outweigh these harms⁶ and after a DCIS diagnosis the baseline risk of a second breast cancer is higher than average, so the balance favors continued imaging. Still, which imaging, how often, and whether to add other options is a real conversation to have with your doctor.

For women with dense breasts or higher baseline risk, your team may discuss supplemental imaging. Breast MRI is the most sensitive option, particularly for higher-grade DCIS.⁷ Ultrasound (handheld or automated, ABUS) can catch cancers mammography misses in dense tissue.⁸ Newer radiation- and compression-free modalities — transmission ultrasound, contrast-enhanced mammography, molecular breast imaging — are being studied and are worth asking about, though the evidence base and availability are still limited.⁹ If cost, discomfort, or anxiety is getting in the way of keeping up with imaging, say so. There are usually workable options, and skipping surveillance entirely is the outcome most likely to cause harm.

2. Daily Habits With the Strongest Evidence to Reduce Breast Cancer Risk

Limit or Eliminate Alcohol

Alcohol is one of the most well-documented modifiable risk factors for breast cancer.¹⁰ In women previously diagnosed with DCIS, drinking 7 or more alcoholic drinks per week was associated with roughly 1.8 times the risk of going on to develop invasive breast cancer.¹¹ There is no level of alcohol consumption that has been shown to be protective for breast tissue. Reducing or eliminating alcohol is one of the most impactful choices you can make.

Move Your Body

Physical activity is among the strongest lifestyle factors associated with reduced risk of breast cancer recurrence and improved survival after a breast cancer diagnosis.¹² The American Cancer Society recommends at least 150 minutes of moderate-intensity aerobic activity per week (or 75 minutes of vigorous activity), plus strength training at least twice a week.¹³ You do not have to be an athlete — even modest amounts of activity below the guideline level have been associated with benefit. Find something you enjoy and can sustain.

Work Toward a Weight That Is Healthy for You

Excess body fat — particularly after menopause — raises circulating estrogen levels and is linked to increased breast cancer risk.¹⁴ In a study of women with a prior DCIS diagnosis, obesity was associated with about a 1.6-fold higher risk of any second breast cancer, and a 2.2-fold higher risk in the opposite breast.¹⁵ If weight is something you want to address, work with your healthcare team on a sustainable, supportive plan. Be kind to yourself in the process.

Don’t Smoke (and Avoid Secondhand Smoke)

The DCIS-specific evidence on smoking is mixed,¹⁶ but smoking is a clearly established risk factor for invasive breast cancer and many other diseases.¹⁷ If you smoke, talk to your doctor about cessation resources — they make a meaningful difference in success rates. Avoid secondhand smoke when you can.

3. Daily Habits That Support Overall Health

Eat a Breast-Healthy Diet

Research broadly supports a diet rich in vegetables, fruits, whole grains, legumes, and fiber, with limited red and processed meat, refined sugar, and ultra-processed foods.¹⁸ Eat whole foods and organic when possible. Specific foods studied for breast health include cruciferous vegetables (broccoli, cauliflower, cabbage), green tea, and traditional levels of soy foods (2–3 servings per day, similar to a Japanese diet, which appear to be safe and possibly protective — even after a breast cancer diagnosis).¹⁹ Vitamin D’s role is still being studied; evidence is mixed but suggestive.²⁰ Ask your doctor whether your vitamin D level should be checked.

Prioritize Sleep

Sleep is when your body repairs itself. Most adults need 7 to 9 hours per night. Insufficient or disrupted sleep — including from shift work — has been linked to a range of health problems, including some cancers.²¹ If sleep is hard for you (a common experience after a DCIS diagnosis), bring it up with your doctor.

Tend to Your Mental Health

A DCIS diagnosis can bring fear, anxiety, and a heavy mental load. Direct evidence that stress affects whether DCIS progresses is limited,²² but managing stress matters for your quality of life and overall health. Mindfulness-based stress reduction and cognitive-behavioral approaches have been studied in breast cancer patients with measurable benefits.²³ Find what works for you — therapy, meditation, time in nature, gentle movement, time with people who support you. See our Coping & Support page for resources.

Reduce Avoidable Chemical Exposures

Some chemicals in everyday products — certain plasticizers (like BPA), pesticides, parabens, and others — can mimic estrogen in the body and have been linked in growing research to breast cancer risk.²⁴ The evidence is still evolving, and most individual exposures are small. Where it is reasonable, consider lower-exposure choices: glass or stainless steel instead of plastic for hot foods and liquids, fragrance-free or third-party-certified personal care products, and a vented kitchen. The Breast Cancer Prevention Partners website is a helpful starting point.

4. Medical Options to Discuss With Your Doctor

Surgery, radiation, and (for some women) active surveillance are typically the first medical decisions you will face after a DCIS diagnosis. We cover those treatment paths in detail on our Treatment Options & Side Effects page. The medical decisions below are ones that often come alongside or follow those treatments — choices you may carry for years.

Endocrine or Hormone Therapy

If your DCIS is hormone-receptor positive, your doctor may discuss adjuvant endocrine therapy (such as tamoxifen or an aromatase inhibitor) to reduce the risk of recurrence in the same breast or a new cancer in the other breast. Long-term follow-up of randomized trials shows tamoxifen meaningfully reduces these risks.²⁵ Lower-dose (“baby tamoxifen”) regimens are also being studied with promising results. This is a personal decision that involves weighing benefits against side effects.

Menopausal Hormone Therapy

If you are considering hormone therapy for menopause symptoms, talk openly with your doctor. Combined estrogen-plus-progestin therapy carries the clearest evidence of increased breast cancer risk and is generally not recommended after a DCIS diagnosis.²⁶ Estrogen-alone therapy has a more nuanced evidence base. Decisions should be individualized.

Family History and Genetic Testing

A personal history of DCIS, combined with certain family history patterns or ancestry, may make you a candidate for genetic testing (BRCA1/2 and other genes). Genetic information can change recommendations for screening intensity, risk-reduction options, and conversations with your relatives. Ask your doctor whether genetic counseling makes sense for you.

5. Be an Active Participant in Your Care

DCIS research is evolving rapidly. Studies increasingly show that many DCIS cases — particularly low-grade cases — carry a low risk of progression, and that less invasive options such as active surveillance, with or without endocrine therapy, may be appropriate for some women.²⁷ Knowing your individual risk profile and your options makes you a stronger advocate for yourself. Visit our News & Updates page to stay current, and our Understanding Your Individual Risk Profile page to learn how risk is assessed.

A Final Note

No single step guarantees prevention — but together, these choices build a foundation for better health. Be patient with yourself. Bring your questions to your medical team. And remember — you are not alone. Our community is here to support you.

Coping & Support    •    Your DCIS FAQs Answered    •    Understanding Your Individual Risk Profile

This content is based on peer-reviewed research and clinical guidelines from organizations including AACR, NCCN, ASCO, the American Cancer Society and others.

1. American Academy of Family Physicians. Breast Cancer Self-Examination clinical recommendation. aafp.org ↩︎
2. Kerlikowske K et al. “Mode of Detection of Second Breast Cancers After DCIS.” Kaiser Permanente Division of Research, 2023. divisionofresearch.kaiserpermanente.org ↩︎
3. ACR Appropriateness Criteria® Imaging After Mastectomy and Breast Reconstruction; NCCN and ASCO surveillance guidelines for early-stage breast cancer including DCIS. acr.org ↩︎
4. Hendrick RE. “Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.” Radiology 2018 — estimates DCIS-specific obligate overdiagnosis at roughly 9%, rising sharply with age (under 1% at age 40, ~30% at age 80). pubs.rsna.org Higher-end estimates appear in broader screening reviews — the Independent UK Panel on Breast Cancer Screening (Marmot review), Lancet 2012, estimated ~19% overdiagnosis among cancers diagnosed during the active screening period — though that figure covers all screen-detected breast cancer, not DCIS alone, and uses a different definition. thelancet.com ↩︎
5. Active surveillance trials for low-risk DCIS currently enrolling or reporting: COMET (US, NCT02926911), LORIS (UK, ISRCTN27544579), and LORD (EORTC 1401-BCG). ↩︎
6. Miglioretti DL et al. “Radiation-Induced Breast Cancer Incidence and Mortality from Digital Mammography Screening: A Modeling Study.” Ann Intern Med 2016. acpjournals.org ↩︎
7. Bakker MF et al. “Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.” DENSE Trial, N Engl J Med 2019. nejm.org ↩︎
8. Systematic review and meta-analysis of adjunct automated breast ultrasound (ABUS) in mammographic screening. mdpi.com ↩︎
9. Transmission-ultrasound reader studies have shown comparable cancer detection performance to 3D mammography in selected settings, with lower recall and no radiation or compression; evidence base is early and population-level mortality data do not yet exist. sciencedirect.com ↩︎
10. Susan G. Komen. Research table: Alcohol and breast cancer risk. komen.org ↩︎
11. Wernli KJ et al. “Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ.” Breast Cancer Res Treat 2022. link.springer.com ↩︎
12. National Cancer Institute. “Exercise and Survival for Women with Breast Cancer.” cancer.gov ↩︎
13. Rock CL et al. “American Cancer Society nutrition and physical activity guideline for cancer survivors.” CA Cancer J Clin 2022. acsjournals.onlinelibrary.wiley.com ↩︎
14. National Cancer Institute. “Obesity and Cancer” fact sheet. cancer.gov ↩︎
15. Williams LA et al. “Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In Situ.” JNCI Cancer Spectrum 2018. academic.oup.com ↩︎
16. See: “Cigarette smoking in relation to risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women.” PubMed. pubmed.ncbi.nlm.nih.gov; and Anticancer Research 2022 retrospective study on smoking and DCIS progression. pubmed.ncbi.nlm.nih.gov ↩︎
17. Breast Cancer Research Foundation. “Smoking and Breast Cancer Risk.” bcrf.org ↩︎
18. World Cancer Research Fund / American Institute for Cancer Research. “Diet, Nutrition, Physical Activity and Breast Cancer.” wcrf.org ↩︎
19. Chi F et al. “Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.” 2018. pubmed.ncbi.nlm.nih.gov ↩︎
20. “Vitamin D and Breast Cancer: Latest Evidence and Future Steps.” PMC. pmc.ncbi.nlm.nih.gov ↩︎
21. International Agency for Research on Cancer (IARC) Monograph 124: Night Shift Work. publications.iarc.who.int ↩︎
22. National Cancer Institute. “Stress and Cancer” fact sheet. cancer.gov ↩︎
23. Antoni MH et al. Reviews of CBSM and MBSR in breast cancer patients show measurable reductions in distress and inflammatory markers. PMC. pmc.ncbi.nlm.nih.gov ↩︎
24. Breast Cancer Prevention Partners. “How strong is the evidence linking chemicals to breast cancer?” bcpp.org ↩︎
25. American Society of Breast Surgeons. “Endocrine Therapy for the Management and Risk Reduction of DCIS.” Consensus statement. breastsurgeons.org ↩︎
26. “Menopausal hormone therapy and breast cancer risk: 21 years from the WHI clinical studies.” 2024. gremjournal.com ↩︎
27. Active surveillance trials in DCIS include LORIS (UK), LORD (EU), and COMET (US). See also DCIS Understood’s News & Updates page for trial summaries. ↩︎